Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: Implications for disease-associated kinases

被引:9
作者
Cheng, Heung-Chin [1 ]
Johnson, Timothy M. [1 ,2 ]
Mills, Ryan D. [1 ,2 ]
Chong, Yuh-Ping [2 ]
Chan, Khai-Chew [1 ]
Culvenor, Janetta G. [2 ]
机构
[1] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
基金
英国医学研究理事会;
关键词
cancer; inhibitors; oncogene; phosphotransferase; pp60C-Src; protein tyrosine kinases; proto-oncogene proteins; Src-family kinases; CHRONIC MYELOGENOUS LEUKEMIA; C-SRC; PARKINSONS-DISEASE; HOMOLOGOUS-KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ABL KINASE; ACTIVATION; INHIBITORS; CSK;
D O I
10.1111/j.1440-1681.2009.05237.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. The Src-family protein tyrosine kinases (SFKs) are multidomain oncogenic protein tyrosine kinases. Their overactivation contributes to cancer formation and progression. Thus, synthetic inhibitors of SFKs are being developed as therapeutics for cancer treatment. Understanding the regulatory and catalytic mechanisms of SFKs is necessary for the development of therapeutic SFK inhibitors. 2. Although many upstream regulators and protein substrates of SFKs have been identified, both the mechanisms of activation and catalysis of SFKs are not fully understood. In particular, it is still unclear how the inactive SFKs undergo conformational transition during activation. The mechanism governing the binding of substrates and the release of products during catalysis is another area that requires investigation. 3. Several recent publications indicate the presence of a 'hydrophobic spine' formed by four conserved interacting hydrophobic residues in the kinase domain of SFKs. In the present review, we discuss how the assembly and disassembly of the hydrophobic spine residues may govern conformational transition of SFKs during activation. In addition to regulation of kinase activity, the hydrophobic spine is implicated to be involved in catalysis. It has been postulated recently that perturbation of the hydrophobic spine residues is a key step in catalysis. 4. Further investigations to decipher the roles of the hydrophobic spine residues in regulation and catalysis of SFKs will benefit the development of therapeutic SFK inhibitors for cancer treatment.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 47 条
[11]   C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases [J].
Chong, Yuh-Ping ;
Chan, Andrew S. ;
Chan, Khai-Chew ;
Williamson, Nicholas A. ;
Lerner, Edwina C. ;
Smithgall, Thomas E. ;
Bjorge, Jeffrey D. ;
Fujita, Donald J. ;
Purcell, Anthony W. ;
Scholz, Glen ;
Mulhern, Terrence D. ;
Cheng, Heung-Chin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) :32988-32999
[12]   The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation [J].
Cowan-Jacob, SW ;
Fendrich, G ;
Manley, PW ;
Jahnke, W ;
Fabbro, D ;
Liebetanz, J ;
Meyer, T .
STRUCTURE, 2005, 13 (06) :861-871
[13]   Small Molecule Recognition of c-Src via the lmatinib-Binding Conformation [J].
Dar, Arvin C. ;
Lopez, Michael S. ;
Shokat, Kevan M. .
CHEMISTRY & BIOLOGY, 2008, 15 (10) :1015-1022
[14]   The gatekeeper residue controls autoactivation of ERK2 via a pathway of intramolecular connectivity [J].
Emrick, Michelle A. ;
Lee, Thomas ;
Starkey, Paul J. ;
Mumby, Marc C. ;
Resing, Katheryn A. ;
Ahn, Natalie G. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (48) :18101-18106
[15]   Kinase activity is required for the toxic effects of mutant LRRK2/dardarin [J].
Greggio, Elisa ;
Jain, Shushant ;
Kingsbury, Ann ;
Bandopadhyay, Rina ;
Lewis, Patrick ;
Kaganovich, Alice ;
van der Brug, Marcel P. ;
Beilina, Alexandra ;
Blackinton, Jeff ;
Thomas, Kelly Jean ;
Ahmad, Rill ;
Miller, David W. ;
Kesavapany, Sashi ;
Singleton, Andrew ;
Lees, Andrew ;
Harvey, Robert J. ;
Harvey, Kirsten ;
Cookson, Mark R. .
NEUROBIOLOGY OF DISEASE, 2006, 23 (02) :329-341
[16]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[17]   The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck [J].
Hanna, Z ;
Weng, XD ;
Kay, DG ;
Poudrier, J ;
Lowell, C ;
Jolicoeur, P .
JOURNAL OF VIROLOGY, 2001, 75 (19) :9378-9392
[18]   Novel 4-anilinoquinazolines with C-6 carbon-linked side chains:: Synthesis and structure-activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitors [J].
Hennequin, LFA ;
Ballard, P ;
Boyle, FT ;
Delouvrié, B ;
Ellston, RPA ;
Halsall, CT ;
Harris, CS ;
Hudson, K ;
Kendrew, J ;
Pearse, JE ;
Ross, HS ;
Smith, P ;
Vincent, JL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (10) :2672-2676
[19]   Clinical and positron emission tomography of Parkinson's disease caused by LRRK2 [J].
Hernandez, DG ;
Paisán-Ruíz, C ;
McInerney-Leo, A ;
Jain, S ;
Meyer-Lindenberg, A ;
Evans, EW ;
Berman, KF ;
Johnson, J ;
Auburger, G ;
Schäffer, AA ;
Lopez, GJ ;
Nussbaum, RL ;
Singleton, AB .
ANNALS OF NEUROLOGY, 2005, 57 (03) :453-456
[20]   Identification of N-Terminal Lobe Motifs that Determine the Kinase Activity of the Catalytic Domains and Regulatory Strategies of Src and Csk Protein Tyrosine Kinases [J].
Huang, Kezhen ;
Wang, Yue-Hao ;
Brown, Alex ;
Sun, Gongqin .
JOURNAL OF MOLECULAR BIOLOGY, 2009, 386 (04) :1066-1077